Modulation of γ2-MSH Hepatoprotection by Antisense Peptides and Melanocortin Subtype 3 and 4 Receptor Antagonists

E-ISSN： 1875-6638|11|3|286-295

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.11, Iss.3, 2015-05, pp. : 286-295

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes

By Schioth H.B. Muceniece R. Larsson M. Mutulis F. Szardenings M. Prusis P. Lindeberg G. Wikberg

European Journal of Pharmacology, Vol. 319, Iss. 2, 1997-01 ,pp. : 369-373

Elsevier

Access to resources Recommend Favorite

Asp 10 in Lys- 2 -MSH determines selective activation of the melanocortin MC 3 receptor

By Oosterom J. Burbach J.P.H. Gispen W.H. Adan R.A.H.

European Journal of Pharmacology, Vol. 354, Iss. 1, 1998-07 ,pp. : 9-11

Elsevier

Access to resources Recommend Favorite

Melanocortin-4 Receptor Antagonists as Potential Therapeutics in the Treatment of Cachexia

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-06 ,pp. : 1131-1136

Bentham Science Publishers

Access to resources Recommend Favorite

Melanocortin-4 Receptor Antagonists for the Treatment of Depression and Anxiety Disorders

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-06 ,pp. : 1145-1151

Bentham Science Publishers

Access to resources Recommend Favorite

Antisense modulation of Toll-like receptor 4 expression

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 12, 2003-12 ,pp. : 1887-1889

Informa Healthcare

Access to resources Recommend Favorite